STUDY OF THE NQO1 RS1800566 POLYMORPHISM AND ASCL1 GENE EXPRESSION IN PATIENTS WITH OCCUPATIONAL TRINITROTOLUENE POISONING
Main Article Content
Abstract
Objectives: To investigate the rs1800566 polymorphism in the NQO1 gene and evaluate ASCL1 gene expression levels in patients with occupational trinitrotoluene (TNT) poisoning. Methods: A case-control and descriptive study was conducted on 200 workers occupationally exposed to trinitrotoluene (TNT), including 100 patients with TNT poisoning and 100 non-poisoned controls from December 2023 to December 2025. The rs1800566 polymorphism of the NQO1 gene was determined using the PCR-RFLP technique, and ASCL1 gene expression levels were relatively quantified by qRT-PCR. Results: The frequencies of AA/AG/GG genotypes in the researched group were 15%, 46%, and 39%, respectively, compared to 25%, 53%, and 22% in the control group. The allele frequencies of A/G were 76/124 in the researched group and 103/97 in controls. The GG genotype was more prevalent in the researched group (p < 0.05). The GG genotype was associated with a higher risk of TNT poisoning compared to the AA genotype (OR = 2.95; p < 0.01), and the G allele was associated with a higher risk compared to the A allele (OR = 1.73; p < 0.01). ASCL1 gene expression levels were lower in the researched group than in the control group, with median values of 0.44 and 0.93, respectively (p < 0.001). Conclusion:The NQO1 rs1800566 polymorphism, particularly the GG genotype and G allele, is associated with an increased risk of occupational TNT poisoning. ASCL1 gene expression is significantly reduced in patients with TNT poisoning compared to the control group.
Keywords
Trinitrotoluene poisoning, NQO1 gene, ASCL1 gene
Article Details
References
2. NQO1 NAD(P)H quinone dehydrogenase 1, NCBI, https://www.ncbi.nlm.nih.gov/ gene/1728.
3. Ross D, and Siegel D. The diverse functionality of NQO1 and its roles in redox control. Redox Biology. 2021; 41:101950.
4. Solta A, Ernhofer B, Boettiger K, et al. Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation. Cancer Metab. 2025; 13(1):16.
5. Bộ Y tế. Thông tư số 15/2016/TT-BYT "Quy định về bệnh nghề nghiệp được hưởng bảo hiểm xã hội”. 2016.
6. Agúndez JA, García-Martín E, Martínez C, et al. NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis. BMC Neurol. 2014; 14:87.
7. Fan Y, Hu D, Feng B, et al. The NQO1 C609T polymorphism and hepatocellular carcinoma risk. Tumor Biology. 2014; 35(8):7343-7350.
8. Peng Q, Lu Y, Lao X, et al. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: Evidence from an updated meta-analysis. Diagn Pathol. 2014; 9:100
9. Nebert DW, Roe AL, Vandale SE, et al. NAD(P)H: Quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: A HuGE review. Genetics in Medicine. 2002; 4(2):62-70.
10. Liu JT and Bain LJ. Arsenic inhibits hedgehog signaling during P19 cell differentiation. Toxicol Appl Pharmacol. 2014; 281(3):243-253.